PF-08046054 by Pfizer for Solid Tumor: Likelihood of Approval

PF-08046054 is under clinical development by Pfizer and currently in Phase I for Solid Tumor.

Konica Minolta’s Microsoft Azure-Hosted Platform Automates Exchange of Healthcare Data

What You Should Know: Konica Minolta launches Konica Minolta Connected Care, a cloud-based workflow automation platform designed to streamline manual processes such as patient intake,

June 21, 2023

American Heart Association launches initiative to tackle recurrent pericarditis

About 40,000 people in the United States experience recurrent pericarditis, or inflammation of the sac-like structure that protects the heart, which can cause chest pain

June 17, 2024

How Practically Applied GenAI Will Enhance Healthcare Operations

Heather Bassett, M.D., Chief Medical Officer with Xsolis The year 2023 marked a milestone for generative AI, bringing unprecedented attention to the immense potential of AI

June 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.